Nov 26, 2019 (Market Insight Reports via COMTEX) --
The term medical marijuana refers to using the whole, unprocessed marijuana plant or its basic extracts to treat symptoms of illness and other conditions. The U.S. Food and Drug Administration (FDA) has not recognized or approved the marijuana plant as medicine.
However, scientific study of the chemicals in marijuana, called cannabinoids, has led to two FDA-approved medications that contain cannabinoid chemicals in pill form. Continued research may lead to more medications.
Because the marijuana plant contains chemicals that may help treat a range of illnesses and symptoms, many people argue that it should be legal for medical purposes. In fact, a growing number of states have legalized marijuana for medical use.
Global Medical Marijuana Market was valued at USD 3.89 Billion in 2019 and is projected to reach USD 19.99 Billion by 2025, growing at a CAGR of 25% from 2018 to 2025.
Ask for sample copy of this report at https://www.marketinsightsreports.com/reports/11051533291/global-medical-marijuana-market-professional-survey-report-2019/inquiry?source=MW&mode=MT
Profiling Top Companies Of Global Medical Marijuana MarketScotts Miracle-Gro, Canopy Growth, GW Pharmaceuticals, Aurora Cannabis, Aphria, MedReLeaf, Insys Therapeutics, Sprott, CanniMed Therapeutics, Horizons Marijuana Life Sciences Index ETF, and Other
MARKET SEGMENTATION BY TYPEDried Flower
Oils + Concentrates
MARKET SEGMENTATION BY APPLICATION
Nausea (from cancer chemotherapy)
Chronic Illness (HIV/Nerve Pain)
SEGMENT BY REGIONS
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Inquire For Discount (special offer:Up To 20% Discount on This Report) https://www.marketinsightsreports.com/reports/11051533291/global-medical-marijuana-market-professional-survey-report-2019/discount?source=MW&mode=MT
Medical Marijuana Market OutlookIncrease in the number of countries approving the use of the product for therapeutic application, increasing geriatric population in need of treatment for chronic diseases, and rising number of medical marijuana clubs have been driving the global Marijuana Market. On the other hand, increasing recreational and personal use of marijuana and strict regulatory laws act as potential restraints for the overall market at a global level.
Medical Marijuana Market Competitive Landscape"Global Medical Marijuana Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as GW Pharmaceuticals PLC, MedReleaf Corporation, Canopy Growth Corporation, Aphria Incorporation, Aurora Cannabis Inc, Medical Marijuana, Inc., Green Relief Inc., Cannabis Sativa, INC., Insys Therapeutics, Inc., and The Peace Naturals Project..Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.
Global Medical Marijuana Market TOC:- Global Medical Marijuana Market Overview, Drivers, Restraints and Opportunities, Segmentation overview
- Global Medical Marijuana Market competition by Manufacturers (2019-2025)
- Production and Consumption by Regions
- Complete profiling and analysis of Manufacturers (2019-2025)
- Manufacturing cost analysis, Materials analysis, Region-wise manufacturing expenses